Last reviewed · How we verify

NCT04234659

PPCM Observational Study (Peripartum Cardiomyopathy)

Completed Last updated 23 February 2026
What this trial tests

trial testing Clinical placement of a temporary IMPELLA® mechanical circulatory support device. in Peripartum Cardiomyopathy in 150 participants. Completed in 5 August 2025.

Timeline
11 January 2021
Primary endpoint
5 August 2025
5 August 2025

Quick facts

Lead sponsorMedical College of Wisconsin
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date11 January 2021
Primary completion5 August 2025
Estimated completion5 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medical College of Wisconsin

Who can join

18 and older, female only, with Peripartum Cardiomyopathy or Cardiogenic Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Peripartum Cardiomyopathy

Currently open trials in the same condition.

Other Medical College of Wisconsin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04234659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing